KRAS and neoplasm: Moreover, the report by Song et al (2018), which reached the same conclusion as our work (i.e., IKKα functions as an NSCLC tumor suppressor), only induced NSCLC development in response to oncogenically activated K-Ras (Song et al, 2018).